Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) shares closed up 47% at $2.44 after the company terminated its PC111 option and license agreement with PinCell following a denied extension request.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) announced favorable Phase 1b CANYON-1 trial results evaluating once-daily oral CRB-913 for obesity, demonstrating statistically significant weight reduction across all cohort dosages.
The filing reported an award of shares, a share forfeiture, and an award of derivative securities.
CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) finance executive Joseph Frank Oldakowski sold 20,000 shares. The filing reports the sale and states that Oldakowski owned 279,067 shares afterward.
CDW Corp (NASDAQ: CDW) awarded Elizabeth H. Connelly 238 shares at $142.60 per share. The award was reported on 10 September 2026.
CDW Corp (NASDAQ: CDW) awarded director Grier Kelly J 7 shares at $142.60 per share.
Celularity Inc. (NASDAQ: CELU) has regained compliance with Nasdaq’s minimum bid-price requirement and its minimum market-value requirement for listed securities. The two listing matters are now closed, while Celularity continues work on a separate periodic-reporting deficiency.
Charles Dirkson R received a share award from Builders FirstSource on Sep 10, with his resulting holding listed at 14,766 shares. The transaction represented about 3.2% of his resulting position.
Chatham Lodging Trust (NYSE: CLDT) awarded director Brown William P 5,000 shares at $0 per share. The transaction left him with 5,000 shares following the award.
Childrens Place, Inc. (NASDAQ: PLCE) held $7.176 million in cash and cash equivalents on August 1, 2026, alongside a $160.080 million revolving loan and $17.833 million in short-term debt. The balance sheet also listed $742.307 million in total assets for the period ended August …